Codes ATC:
M04AA01
EMLc
Indication
Tumour lysis syndrome
Code ICD11:
5C70
INN
Allopurinol
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Solid:
100 mg
(EMLc)
;
300 mg
(EMLc)
Historique des statuts LME
Ajouté pour la première fois en 2007
(TRS
950)
Sexe
Tous
Âge
Enfants (1 mois - 12 ans)
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Allopurinol was included on the complementary list of the first EMLc in 2007. The EMLc Subcommittee considered that allopurinol was necessary for management of children within oncology practice and that it should be included in cytotoxics and adjuvant medicines section of the EMLc for this indication.